Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Aaron Ahlburn

Managing Director and Senior Director, Research, JLL
Amy Gerber

Executive Managing Director, Cushman & Wakefield
Bill Luttrell

Senior Locations Strategist, Werner Global Logistics, Werner Enterprises
Bradley Migdal

Senior Managing Director, Business Incentives Practice, Cushman & Wakefield, Inc.
Brian Corde

Managing Partner, Atlas Insight
Christine Bustamante

National Co-Leader, Global Location and Expansion Services, State and Local Tax, KPMG LLP
Dan Levine

Practice Leader, Location Strategies and Economic Development, Oxford Economics, Inc.
Dan White

Senior Economist, Moody's Analytics
Dean J. Uminski, CEcD

Partner, Crowe Horwath
Dennis Cuneo

Partner , Fisher & Phillips
Eric Stavriotis

Senior Vice President, Advisory & Transaction Services, CBRE, Inc.
Gregory Burkart

Managing Director and City Leader, Site Selection & Incentives Advisory , Duff & Phelps, LLC
Josh Bays

Principal, Site Selection Group, LLC
Joshua Wright

VP, Economic and Workforce Development, Emsi
Les Cranmer

Senior Managing Director, Savills Studley
Marc Beauchamp

President & CEO, The CAI Global Group
Margy Sweeney

Founder and CEO, Akrete, Inc.
Minah Hall

Managing Director, True Partners Consulting LLC
Paul Naumoff

Principal, National Director of Tax Credits & Incentives Advisory Services, EY Global/Americas
Scott Kupperman

Founder, Kupperman Location Solutions
Stephen Gray

CEO, Gray Construction
Trula Hensler

Senior Marketing Manager, Baker Tilly Virchow Krause, LLP

Expansion of Biotech Company in Florida to Add Over 160 Jobs

Area Development News Desk

08/16/2011

Rapid Pathogen Screening Inc. (RPS) has announced it expects to add 164 employees to its existing 25-employee workforce over the next five years as part of its Sarasota County, FL, headquarters expansion project.

Currently RPS occupies a 3,300-sq.-ft. facility in Lakewood Ranch, and could require 35,000 additional square feet within five years, according to CEO Thomas Orsini.

This emerging biotech company makes rapid diagnostic tests for a variety of diseases and conditions. Its initial product offering is the FDA-cleared RPS Adeno Detector, sold in the U.S. and internationally. Health care providers use the test kit to determine the underlying source of infectious conjunctivitis (commonly known as "pink eye").

"We expect to expand significantly as we accomplish fundraising objectives, allowing us to bring nine new products to market," said Orsini. "State and community support, and our desire to partner with local business ventures to attract and retain top-caliber talent, makes Sarasota County an appealing location for our headquarters."

Mark Huey, president and CEO of the Economic Development Corporation of Sarasota County (EDC), called it "a hidden gem in Sarasota County's growing biotech sector, quietly going about its business of creating breakthrough medical technology."

RPS recently qualified for for local and state economic development incentives totalling $820,000. The State of Florida, through its Qualified Target Industry tax refund program, committed $656,000 to the company's expansion. Sarasota County pledged a local match of $164,000. The funds will be provided if the company hires 164 permanent, full-time employees over the next five years, and pays an average wage of $72,104.